Company news
Oxford BioDynamics PLC news in 2022
Oxford BioDynamics PLC's news releases, calls and decks from 2022, newest first.
Notice of FY22 Results and Investor Webinar
December 21, 2022
OBD in San Francisco for JPM Healthcare conf 2023
December 19, 2022
Initial assessment of EpiSwitch assay in ALS trial
December 16, 2022
Exercise period extension - existing share options
December 14, 2022
Discussion about EpiSwitch CiRT at Key Summit
November 21, 2022
Second Price Monitoring Extn
November 18, 2022
Price Monitoring Extension
November 18, 2022
Total Voting Rights
November 1, 2022
Result of General Meeting, Director/PDMR Dealings
October 27, 2022
Result of Open Offer
October 25, 2022
Proposed Placing and Open Offer
October 7, 2022
US Reimbursement Code for CiRT now available
October 3, 2022
ESMO data highlights unique benefit of EpiSwitch
September 15, 2022
CiRT highlighted at ESMO 2022 presentation
September 6, 2022
US reimbursement code for EpiSwitch® CiRT
July 5, 2022
EpiSwitch® CiRT now available in the UK
June 21, 2022
Notice of Interim Results Webinar
June 17, 2022
OBD EpiSwitch® CiRT well received at ASCO 2022
June 14, 2022
OBD to present CiRT clinical utility data at ASCO
May 5, 2022
Results of Annual General Meeting
March 30, 2022
Publication of 2021 annual report
March 1, 2022
US launch of EpiSwitch® CiRT for oncology
February 25, 2022
Final Results
January 25, 2022